DR. AMMAR AL-HALLAK, M.D.

JONESBORO, AR

Research Active
Internal Medicine - Interventional Cardiology NPI registered 21+ years 1 publication 2017 – 2017 NPI: 1962407940
Internal Medicine - Interventional Cardiology
Survival RateHospital MortalityHeart Valve Prosthesis ImplantationTricuspid Valve InsufficiencyTricuspid Valve

Practice Location

201 E OAK AVE
JONESBORO, AR 72401

Phone: (870) 935-6729

What does AMMAR AL-HALLAK research?

Dr. Al-Hallak studies tricuspid regurgitation (TR), which is a condition affecting the heart where the tricuspid valve does not close properly, leading to blood flow issues. His research focuses on the surgical treatments for this condition, examining how many patients undergo these surgeries and the outcomes that follow. He looks specifically at the risks involved in isolated surgeries compared to surgeries performed alongside other heart operations, thus aiming to improve care for individuals with severe TR.

Key findings

  • From 2003 to 2014, approximately 45,000 patients underwent surgery for tricuspid regurgitation.
  • 15% of the surgeries for TR were conducted alone, while 85% were part of other heart surgeries.
  • Isolated surgeries for tricuspid regurgitation had a 10.9% in-hospital death rate and a 34.1% chance of requiring a pacemaker post-surgery.

Frequently asked questions

Does Dr. Al-Hallak study tricuspid regurgitation?
Yes, Dr. Al-Hallak focuses on the surgical treatment of tricuspid regurgitation, analyzing patient outcomes.
What risks are associated with tricuspid regurgitation surgery?
His research shows that isolated surgeries for TR have a 10.9% in-hospital death rate and a high chance of needing a pacemaker.
How many patients have surgery for tricuspid regurgitation?
Approximately 45,000 patients underwent surgery for tricuspid regurgitation between 2003 and 2014.

Publications in plain English

Contemporary Trends in the Use and Outcomes of Surgical Treatment of Tricuspid Regurgitation.

2017

Journal of the American Heart Association

Alqahtani F, Berzingi CO, Aljohani S, Hijazi M, Al-Hallak A +1 more

Plain English
This study looked at trends in surgery for a heart condition called tricuspid regurgitation (TR) from 2003 to 2014, finding that around 45,000 patients had surgery for it. The research discovered that 15% of these surgeries were performed alone, while 85% were done alongside other heart surgeries, with isolated surgery having a higher risk of complications, including a 10.9% in-hospital death rate and a 34.1% chance of needing a pacemaker. This is important because it highlights that even though surgery for TR is rising, it involves significant risks and costs, suggesting a need for better treatment options for these patients. Who this helps: This helps patients with severe tricuspid regurgitation and their doctors.

PubMed

Frequent Co-Authors

Fahad Alqahtani Chalak O Berzingi Sami Aljohani Mohamad Hijazi Mohamad Alkhouli

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.